Providing comprehensive and flexible analytical solutions to accelerate the development and approval of biologics

• State-of-the-art analytical methods to thoroughly assess and characterise critical quality attributes
• Science-driven analytical data and characterisation packages for demonstration of biosimilarity and establishing totality of evidence
• Phase-appropriate lifecycle approach to analytics for method development, qualification and validation
• Release and stability testing to support clients’ successful product launch in regulated markets including FDA, EMA and PMDA
• Global cGMP quality systems to support clinical and commercial biologics

Download brochure below: